Showing papers on "Dose profile published in 2005"

Precise radiochromic film dosimetry using a flat-bed document scanner

Abstract: In this study, a measurement protocol is presented that improves the precision of dose measurements using a flat-bed document scanner in conjunction with two new GafChromic® film models, HS and Prototype A EBT exposed to 6MV photon beams. We established two sources of uncertainties in dose measurements, governed by measurement and calibration curve fit parameters contributions. We have quantitatively assessed the influence of different steps in the protocol on the overall dose measurement uncertainty. Applying the protocol described in this paper on the Agfa Arcus II flat-bed document scanner, the overall one-sigma dose measurement uncertainty for an uniform field amounts to 2% or less for doses above around 0.4Gy in the case of the EBT (Prototype A), and for doses above 5Gy in the case of the HS model GafChromic® film using a region of interest 2×2mm2 in size.

Experimental characterization and physical modelling of the dose distribution of scanned proton pencil beams

Abstract: In this paper we present the pencil beam dose model used for treatment planning at the PSI proton gantry, the only system presently applying proton therapy with a beam scanning technique. The scope of the paper is to give a general overview on the various components of the dose model, on the related measurements and on the practical parametrization of the results. The physical model estimates from first physical principles absolute dose normalized to the number of incident protons. The proton beam flux is measured in practice by plane-parallel ionization chambers (ICs) normalized to protons via Faraday-cup measurements. It is therefore possible to predict and deliver absolute dose directly from this model without other means. The dose predicted in this way agrees very well with the results obtained with ICs calibrated in a cobalt beam. Emphasis is given in this paper to the characterization of nuclear interaction effects, which play a significant role in the model and are the major source of uncertainty in the direct estimation of the absolute dose. Nuclear interactions attenuate the primary proton flux, they modify the shape of the depth-dose curve and produce a faint beam halo of secondary dose around the primary proton pencil beam in water. A very simple beam halo model has been developed and used at PSI to eliminate the systematic dependences of the dose observed as a function of the size of the target volume. We show typical results for the relative (using a CCD system) and absolute (using calibrated ICs) dosimetry, routinely applied for the verification of patient plans. With the dose model including the nuclear beam halo we can predict quite precisely the dose directly from treatment planning without renormalization measurements, independently of the dose, shape and size of the dose fields. This applies also to the complex non-homogeneous dose distributions required for the delivery of range-intensity-modulated proton therapy, a novel therapy technique developed at PSI.

Spectral discrimination of Čerenkov radiation in scintillating dosimeters

Abstract: Radiation therapy accelerators require highly accurate dose deposition and the output must be monitored frequently and regularly. Ionization chambers are the primary tool for this control, but their size, their high voltage needed, and the correction needed for electrons make them unsuitable for use during patient treatment. We have developed a small (1-mm-diam and 1-mm-long active part), flexible, and water-equivalent dosimeter. It is suitable for photon and electron beams without corrections, and performs on line dose measurements. This detector is based on only one scintillating fiber and a CCD camera. A new signal processing is used to remove the effect of Cerenkov radiation background, which only requires a preliminary calibration. Central-axis depth-dose distribution comparisons have been achieved with standard ionization chambers, over a range from 8 to 25 MV photons and from 6 to 21 MeV electrons in order to validate this calibration. Results show a very good agreement, with less than 1% difference between the two detectors.

Monte Carlo- versus pencil-beam-/collapsed-cone-dose calculation in a heterogeneous multi-layer phantom.

Abstract: The aim of this work was to evaluate the accuracy of dose predicted in heterogeneous media by a pencil beam (PB), a collapsed cone (CC) and a Monte Carlo (MC) algorithm. For this purpose, a simple multi-layer phantom composed of Styrofoam and white polystyrene was irradiated with 10 x 10 cm2 as well as 20 x 20 cm2 open 6 MV photon fields. The beam axis was aligned parallel to the layers and various field offsets were applied. Thereby, the amount of lateral scatter was controlled. Dose measurements were performed with an ionization chamber positioned both in the central layer of white polystyrene and the adjacent layers of Styrofoam. It was found that, in white polystyrene, both MC and CC calculations agreed satisfactorily with the measurements whereas the PB algorithm calculated 12% higher doses on average. By studying off-axis dose profiles the observed differences in the calculation results increased dramatically for the three algorithms. In the regions of low density CC calculated 10% (8%) lower doses for the 10 x 10 cm2 (20 x 20 cm2) fields than MC. The MC data on the other hand agreed well with the measurements, presuming that proper replacement correction for the ionization chamber embedded in Styrofoam was performed. PB results evidently did not account for the scattering geometry and were therefore not really comparable. Our investigations showed that the PB algorithm generates very large errors for the dose in the vicinity of interfaces and within low-density regions. We also found that for the used CC algorithm large deviations for the absolute dose (dose/monitor unit) occur in regions of electronic disequilibrium. The performance might be improved by better adapted parameters. Therefore, we recommend a careful investigation of the accuracy for dose calculations in heterogeneous media for each beam data set and algorithm.

Enlarged longitudinal dose profiles in cone-beam CT and the need for modified dosimetry

Abstract: In order to examine phantom length necessary to assess radiation dose delivered to patients in cone-beam CT with an enlarged beamwidth, we measured dose profiles in cylindrical phantoms of sufficient length using a prototype 256-slice CT-scanner developed at our institute. Dose profiles parallel to the rotation axis were measured at the central and peripheral positions in PMMA (polymethylmethacrylate) phantoms of 160 or 320 mm diameter and 900 mm length. For practical application, we joined unit cylinders (150 mm long) together to provide phantoms of 900 mm length. Dose profiles were measured with a pin photodiode sensor having a sensitive region of approximately 2.8 x 2.8 mm2 and 2.7 mm thickness. Beamwidths of the scanner were varied from 20 to 138 mm. Dose profile integrals (DPI) were calculated using the measured dose profiles for various beamwidths and integration ranges. For the body phantom (320-mm-diam phantom), 76% of the DPI was represented for a 20 mm beamwidth and 60% was represented for a 138 mm beamwidth if dose profiles were integrated over a 100 mm range, while more than 90% of the DPI was represented for beamwidths between 20 and 138 mm if integration was carried out over a 300 mm range. The phantom length and integration range for dosimetry of cone-beam CT needed to be more than 300 mm to represent more than 90% of the DPI for the body phantom with the beamwidth of more than 20 mm. Although we reached this conclusion using the prototype 256-slice CT-scanner, it may be applied to other multislice CT-scanners as well.

Three-dimensional IMRT verification with a flat-panel EPID

Abstract: A three-dimensional (3D) intensity-modulated radiotherapy (IMRT) pretreatment verification procedure has been developed based on the measurement of two-dimensional (2D) primary fluence profiles using an amorphous silicon flat-panel electronic portal imaging device(EPID). As described in our previous work, fluence profiles are extracted from EPIDimages by deconvolution with kernels that represent signal spread in the EPID due to radiation and optical scattering. The deconvolution kernels are derived using Monte Carlo simulations of dose deposition in the EPID and empirical fitting methods, for both 6 and 15 MV photon energies. In our new 3D verification technique, 2D fluence modulation profiles for each IMRT field in a treatment are used as input to a treatment planning system (TPS), which then generates 3D doses. Verification is accomplished by comparing this new EPID-based 3D dose distribution to the planned dose distribution calculated by the TPS. Thermoluminescent dosimeter(TLD) point dose measurements for an IMRT treatment of an anthropomorphic phantom were in good agreement with the EPID-based 3D doses; in contrast, the planned dose under-predicts the TLD measurement in a high-gradient region by approximately 16%. Similarly, large discrepancies between EPID-based and TPS doses were also evident in dose profiles of small fields incident on a water phantom. These results suggest that our 3D EPID-based method is effective in quantifying relevant uncertainties in the dose calculations of our TPS for IMRT treatments. For three clinical head and neck cancer IMRT treatment plans, our TPS was found to underestimate the mean EPID-based doses in the critical structures of the spinal cord and the parotids by ∼ 4 Gy (11%–14%). According to radiobiological modeling calculations that were performed, such underestimates can potentially lead to clinically significant underpredictions of normal tissue complication rates.

Ion recombination correction for very high dose-per-pulse high-energy electron beams.

Abstract: The parallel-plate ionization chamber is the recommended tool for the absorbed dose measurement in pulsed high-energy electron beams. Typically, the electron beams used in radiotherapy have a dose-per-pulse value less then 0.1 cGy/pulse. In this range the factor to correct the response of an ionization chamber for the lack of complete charge collection due to ion recombination (ksat) can be properly evaluated with the standard "two voltage" method proposed by the international dosimetric reports. Very high dose-per-pulse electron beams are employed in some special Linac dedicated to the Intra-Operatory-Radiation-Therapy (IORT). The high dose-per-pulse values (3-13 cGy/pulse) characterizing the IORT electron beams allow to deliver the therapeutic dose (10-20 Gy) in less than a minute. This considerably reduces the IORT procedure time, but some dosimetric problems arise because the standard method to evaluate ksat overestimates its value by 20%. Moreover, if the dose-per-pulse value >1 cGy/pulse, the dependence of ksat on the dose-per-pulse value cannot be neglected for relative dosimetry. In this work the dependence of ksat on the dose-per-pulse value is derived, based on the general equation that describes the ion recombination in the Boag theory. A new equation for ksat, depending on known or measurable quantities, is presented. The new ksat equation is experimentally tested by comparing the absorbed doses to water measured with parallel-plate ionization chambers (Roos and Markus) to that measured using dose-per-pulse independent dosimeters, such as radiochromic films and chemical Fricke dosimeters. These measurements are performed in the high dose-per-pulse (3-13 cGy/pulse) electron beams of the IORT dedicated Linac Hitesys Novac7 (Aprilia-Latina, Italy). The dose measurements made using the parallel-plate chambers and those made using the dose-per-pulse independent dosimeters are in good agreement ( 1 cGy/pulse) electron-beam dosimetry.

Radiotherapy with laser-plasma accelerators: Monte Carlo simulation of dose deposited by an experimental quasimonoenergetic electron beam

Abstract: The most recent experimental results obtained with laser-plasma accelerators are applied to radio-therapy simulations. The narrow electron beam, produced during the interaction of the laser with the gas jet, has a high charge (0.5 nC) and is quasimonoenergetic (170 +/- 20 MeV). The dose deposition is calculated in a water phantom placed at different distances from the diverging electron source. We show that, using magnetic fields to refocus the electron beam inside the water phantom, the transverse penumbra is improved. This electron beam is well suited for delivering a high dose peaked on the propagation axis, a sharp and narrow tranverse penumbra combined with a deep penetration.

Absorbed dose to water reference dosimetry using solid phantoms in the context of absorbed-dose protocols.

Abstract: For reasons of phantom material reproducibility, the absorbed dose protocols of the American Association of Physicists in Medicine (AAPM) (TG-51) and the International Atomic Energy Agency (IAEA) (TRS-398) have made the use of liquid water as a phantom material for reference dosimetry mandatory. In this work we provide a formal framework for the measurement of absorbed dose to water using ionization chambers calibrated in terms of absorbed dose to water but irradiated in solid phantoms. Such a framework is useful when there is a desire to put dose measurements using solid phantoms on an absolute basis. Putting solid phantom measurements on an absolute basis has distinct advantages in verification measurements and quality assurance. We introduce a phantom dose conversion factor that converts a measurement made in a solid phantom and analyzed using an absorbed dose calibration protocol into absorbed dose to water under reference conditions. We provide techniques to measure and calculate the dose transfer from solid phantom to water. For an Exradin A12 ionization chamber, we measured and calculated the phantom dose conversion factor for six Solid Water phantoms and for a single Lucite phantom for photon energies between 60Co and 18 MV photons. For Solid Water of certified grade, the difference between measured and calculated factors varied between 0.0% and 0.7% with the average dose conversion factor being low by 0.4% compared with the calculation whereas for Lucite, the agreement was within 0.2% for the one phantom examined. The composition of commercial plastic phantoms and their homogeneity may not always be reproducible and consistent with assumed composition. By comparing measured and calculated phantom conversion factors, our work provides methods to verify the consistency of a given plastic for the purpose of clinical reference dosimetry.

Dosimetric quality assurance for intensity-modulated radiotherapy feasibility study for a filmless approach.

Abstract: Test and comparison of various 2–D real–time detectors for dosimetric quality assurance (QA) of intensity–modulated radiotherapy (IMRT) with the vision to replace radiographic films for 2–D dosimetry. All IMRT treatment plans were created with the Konrad software (Siemens OCS). The final dose calculation was also carried out in Konrad. A Mevatron Primus (Siemens OCS) linear accelerator which provides 6–MV and 15–MV highenergy photon beams was used for the delivery of segmented multileaf–modulated IMRT. Three different 2–D detectors, each based on a different physical (interaction) principle, were tested for the field–related IMRT verification: (1) the MapCheck diode system (Sun Nuclear), (2) the I’mRT QA scintillation detector (Scanditronix/Wellhofer), and the Seven29 ionization chamber array (PTW). The performance of these detector arrays was evaluated against IMRT dose distributions created and calculated with Konrad and the results obtained were compared with film measurements performed with radiographic films (EDR2, Kodak). Additionally, measurements were performed with point detectors, such as diamond, diodes (PTW) and ionization chambers (PTW, Scanditronics/ Wellhofer) and radiochromic films (GafChromic film MD55, ISP). The results obtained with all three 2–D detector systems were in good agreement with calculations performed with the treatment–planning system and with the standard dosimetric tools, i.e., films or various point dose detectors. It could be shown that all three systems offer dosimetric characteristics required for performing field–related IMRT QA with relative dose measurements. The accuracy of the 2–D detectors was mostly ± 3% normalized to dose maximum for a wide dynamic range. The maximum deviations did not exceed ± 5% even in regions with a steep dose gradient. The main differences between the detector systems were the spatial resolution, the maximal field size, and the ability to perform absolute dosimetric measurements. Commercial 2–D detectors have the potential to replace films as an “area detector” for field–related verification of IMRT. The on–line information provided by the respective systems can even improve the efficiency of the QA procedures.

In vivo absorbed dose measurements in mammography using a new real-time luminescence technique

Abstract: A dosimetry system based on radioluminescence (RL) and optically stimulated luminescence (OSL) from carbon doped aluminium oxide (Al2O3:C) crystals was developed for in vivo absorbed dose measurements in mammography. A small cylindrical crystal of Al2O3:C (diameter 0.48 mm and length 2 mm) was coupled to the end of a 1 mm diameter optical fibre cable. Owing to their small size and characteristic shape, these probes can be placed on the body surface in the field of view during the examination, without compromising the reading of the mammogram. Our new technique was tested with a mammography unit (Siemens Mammomat 3000) and screen-film technique over a range of clinically relevant X-ray energies. The results were compared with those obtained from an ionization chamber usually used for the determination of absorbed dose in mammography. The reproducibility of measurements was around 3% (1 standard deviation) at 4.5 mGy for both RL and OSL data. The dose response was found to be linear between 4.5 mGy and 30 mGy. The energy dependence of the system is around 18% between 23 kV and 35 kV. In vivo measurements were performed during three patient examinations. It was shown that entrance and exit doses could be measured. The presence of the small probes did not significantly interfere with the diagnostic quality of the images. Entrance doses estimated by RL/OSL results agreed within 3% with entrance surface dose values calculated from the ionization chamber measurements. These results indicate a considerable potential for use in routine control and in vivo dose measurements in mammography.

A preliminary study of the novel application of normoxic polymer gel dosimeters for the measurement of CTDI on diagnostic x-ray CT scanners

Abstract: Computer tomography dose index (CTDI) is a measurement undertaken during acceptance testing and subsequent quality assurance measurements of diagnostic x-ray CT scanners for the determination of patient dose. Normoxic polymer gel dosimeters have been used for the first time to measure dose and subsequently CTDI during acceptance testing of a CT scanner and compared with the conventional ionization chamber measurement for a range of imaging protocols. The normoxic polymer gel dosimeter was additionally used to simultaneously determine slice-width dose profiles and CTDI in the transaxial plane, the measurements of which are usually determined with thermoluminescent dosimetry or film. The resulting CTDI for all slice widths calculated from the normoxic polymer gel dosimeter were within corresponding ionization chamber CTDI values. Slice-width dose-profiles full-width half-maximum values from the normoxic polymer gel dosimeter were compared to the slice sensitivity profiles and were within the tolerances of the manufacturer. Normoxic polymer gel dosimeters have been shown to be a useful device for determining CTDI and dose distributions for CT equipment, and provide additional information not possible with just the use of an ionization chamber.

Development and characterization of a tissue equivalent plastic scintillator based dosimetry system.

Abstract: High precision techniques in radiation therapy, such as intensity modulated radiation therapy, offer the potential for improved target coverage and increased normal tissue sparing compared with conformal radiotherapy. The complex fluence maps used in many of these techniques, however, often lead to more challenging quality assurance with dose verification being labor-intensive and time consuming. A prototype dose verification system has been developed using a tissue equivalent plastic scintillator that provides easy-to-acquire, rapid, digital dose measurements in a plane perpendicular to the beam. The system consists of a water-filled Lucite phantom with a scintillator screen built into the top surface. The phantom contains a silver coated plastic mirror to reflect scintillation light towards a viewing window where it is captured using a charge coupled devicecamera and a personal computer. Optical photon spread is removed using a microlouvre optical collimator and by deconvolving a glare kernel from the raw images. A characterization of the system was performed that included measurements of linear output response, dose rate dependence, spatial linearity, effective pixel size, signal uniformity and both short- and long-term reproducibility. The average pixel intensity for static, regular shaped fields between 3 cm × 3 cm and 12 cm × 12 cm imaged with the system was found to be linear in the dose delivered with linear regression analysis yielding a correlation coefficient r 2 > 0.99 . Effective pixel size was determined to be 0.53 mm ∕ pixel . The system was found to have a signal uniformity of 5.6% and a long-term reproducibility/stability of 1.7% over a 6 month period. The system’s ability to verify a dynamic treatment field was evaluated using 60 ° dynamic wedged fields and comparing the results to two-dimensional film dosimetry. Results indicate agreement with two-dimensional film dosimetry distributions within 8% inside the field edges. With further development, this system promises to provide a fast, directly digital, and tissue equivalent alternative to current dose verification systems.

Dose distribution from x-ray microbeam arrays applied to radiation therapy: An EGS4 Monte Carlo study

Abstract: We present EGS4 Monte Carlo calculations of the spatial distribution of the dose deposited by a single x-ray pencil beam, a planar microbeam, and an array of parallel planar microbeams as used in radiation therapy research. The profiles of the absorbed dose distribution in a phantom, including the peak-to-valley ratio of the dose distribution from microbeam arrays, were calculated at micrometer resolution. We determined the dependence of the findings on the main parameters of photon and electron transport. The results illustrate the dependence of the electron range and the deposited in-beam dose on the cut-off energy, of the electron transport, as well as the effects on the dose profiles of the beam energy, the array size, and the beam spacing. The effect of beam polarization also was studied for a single pencil beam and for an array of parallel planar microbeams. The results show that although the polarizationeffect on the dose distribution from a 3 cm × 3 cm microbeam array inside a water phantom is large enough to be measured at the outer side of the array (16% difference of the deposited dose for x-ray beams of 200 keV), it is not detectable at the array’s center, thus being irrelevant for the radiation therapy purposes. Finally we show that to properly compare the dose profiles determined with a metal oxide semiconductor field emission transistordetector with the computational method predictions, it is important to simulate adequately the size and the material of the device’s Si active element.

Initial clinical results of an in vivo dosimeter during external beam radiation therapy

Abstract: Purpose: An implantable radiation dosimeter has been developed to monitor dose delivered at depth in patients undergoing external beam therapy. A clinical pilot study was conducted to test the safety, efficacy, and utility of the device. Methods and Materials: Ten patients, all with unresectable malignant disease, were enrolled to assess implantation risk and movement of the device in the body and to compare the in vivo measured dose to the value predicted by the treatment planning system software. Results: Migration of the sensor away from the point of original placement was noted in only 1 patient (due to unconsolidated host tissue) and no adverse events were recorded during the implantation procedure or thereafter. Daily dose measurements were recorded successfully for all sensors in all patients. Variance between measured and predicted dose values was reported as a frequency of error at the ≥5% and ≥8% levels. The error frequency at the ≥8% level was as high as 47%, 29%, and 21% for lung, prostate, and rectal tumors, respectively. Conclusions: The implantable dosimeter was found to be safe and effective in measuring dose at depth. There are many factors that can influence delivered dose, and the implantable dosimeter measures the net effect of these factors. The daily sensor readings provide a new tool for rigorous treatment quality assurance.

Preliminary evaluation of implantable MOSFET radiation dosimeters.

Abstract: In this paper, we report on measurements performed on a new prototype implantable radiation detector that uses metal-oxide semiconductor field effect transistors (MOSFETs) designed for in vivo dosimetry. The dosimeters, which are encapsulated in hermetically sealed glass cylinders, are used in an unbiased mode during irradiation, unlike other MOSFET detectors previously used in radiotherapy applications. They are powered by radio frequency telemetry for dose measurements, obviating the need for a power supply within each capsule. We have studied the dosimetric characteristics of these MOSFET detectors in vitro under irradiation from a 60Co source. The detectors show a dose reproducibility generally within 5% or better, with the main sources of error being temperature fluctuations occurring between the pre- and post-irradiation measurements as well as detector orientation. A better temperature-controlled environment leads to a reproducibility within 2%. Our preliminary in vitro results show clearly that true non-invasive in vivo dosimetry measurements are feasible and can be performed remotely using telemetric technology.

In vivo dosimetry with MOSFETs: Dosimetric characterization and first clinical results in intraoperative radiotherapy

Abstract: Purpose: To investigate the use of metal oxide silicon field effect transistors (MOSFETs) as in vivo dosimetry detectors during electron beams at high dose-per-pulse intraoperative radiotherapy. Methods and Materials: The MOSFET system response in terms of reproducibility, energy, dose rate and temperature dependence, dose-linearity from 1 to 25 Gy, angular response, and dose perturbation was analyzed in the 6–9-MeV electron beam energy range produced by an intraoperative radiotherapy-dedicated mobile accelerator. We compared these with the 6- and 9-MeV electron beams produced by a conventional accelerator. MOSFETs were also used in clinical dosimetry. Results: In experimental conditions, the overall uncertainty of the MOSFET response was within 3.5% (±SD). The investigated electron energies and the dose rate did not significantly influence the MOSFET calibration factors. The dose perturbation was negligible. In vivo dosimetry results were in accordance with the predicted values within ±5%. A discordance occurred either for an incorrect position of the dosimeter on the patient or when a great difference existed between the clinical and calibration setup, particularly when performing exit dose measurements. Conclusion: Metal oxide silicon field effect transistors are suitable for in vivo dosimetry during intraoperative radiotherapy because their overall uncertainty is comparable to the accuracy required in target dose delivery.

Patient specific treatment verifications for helical tomotherapy treatment plans.

Abstract: We performed two-dimensional treatment verifications for ten patients planned and treated with helical tomotherapy. The treatment verification consisted of a film measurement as well as point dose measurements made with an ion chamber. The agreement between the calculated and the measured film dose distributions was evaluated with the gamma index calculated for three sets of criteria (2 mm and 2%, 4 mm and 3%, and 3 mm and 5%) as recommended in the literature. Good agreement was found between measured and calculated distributions without any need of normalization of the dose data but with dose map registration using reference marks. In this case, 69.8 ± 17.2 % , 92.6 ± 9.0 % , and 93.4 ± 8.5 % passed the 2 mm and 2%, 4 mm and 3%, and 3 mm and 5% criteria, respectively. Agreement was excellent when both normalization and manual registration of the dose maps was employed. In this case 91.2 ± 5.6 % , 99.0 ± 1.4 % , and 99.5 ± 0.8 % passed the 2 mm and 2%, 4 mm and 3%, and 3 mm and 5% criteria, respectively. The mean percent discrepancy for the point dose measurements was − 0.5 ± 1.1 % , − 2.4 ± 3.7 % , − 1.1 ± 7.3 % for the high dose, low dose, and critical structure point, respectively. Three criteria for a satisfactory treatment verification in the high dose regions of a plan were established. For the un-normalized reference mark registered data 80% of pixels must pass the 3 mm and 5% criteria. For the normalized and manually registered data, 80% must pass the 2 mm and 2% criteria, and the point dose measurement must be within 2% of the calculated dose. All low dose region/critical structure point dose measurements were evaluated on a patient by patient basis. The criteria we recommend can be useful for the routine evaluation of treatment plans for tomotherapy systems.

Suitability of radiochromic medium for real-time optical measurements of ionizing radiation dose.

Abstract: A system, consisting of a novel optical fiber-based readout configuration and model-based method, has been developed to test suitability of a certain radiochromic medium for real-time measurements of ionizing radiation dose. Using this system with the radiochromic film allowed dose measurements to be performed during, and immediately after, exposure. The rates of change in OD before, during, and after exposure differ, and the change in OD during exposure was found to be proportional to applied dose in the tested range of 0-4 Gy. Estimating applied dose within an average error of less than 5% did not require a waiting time of 24-48 h as generally recommended with this radiochromic film. The errors can be further reduced by performing a calibration for each individual dosimeter setup instead of relying on batch calibration. Measurements of change in OD were found to be independent of dose-rate in the 95-570 cGy/min range for applied dose of 1 Gy or less. Some error was introduced due to dose-rate variation for doses of 2 Gy and above. The major limiting factor in utilizing this radiation sensitive medium for real-time in vivo dosimetry is the strong dependence on temperature in the clinically relevant range of 20-38 deg.more » C.« less

Measurement of radiation dose in dental radiology

Abstract: Patient dose audit is an important tool for quality control and it is important to have a well-defined and easy to use method for dose measurements. In dental radiology, the most commonly used dose parameters for the setting of diagnostic reference levels (DRLs) are the entrance surface air kerma (ESAK) for intraoral examinations and dose width product (DWP) for panoramic examinations. DWP is the air kerma at the front side of the secondary collimator integrated over the collimator width and an exposure cycle. ESAK or DWP is usually measured in the absence of the patient but with the same settings of tube voltage (kV), tube current (mA) and exposure time as with the patient present. Neither of these methods is easy to use, and, in addition, DWP is not a risk related quantity. A better method of monitoring patient dose would be to use a dose area product (DAP) meter for all types of dental examinations. In this study, measurements with a DAP meter are reported for intraoral and panoramic examinations. The DWP is also measured with a pencil ionisation chamber and the product of DWP and the height H (DWP x H) of the secondary collimator (measured using film) was compared to DAP. The results show that it is feasible to measure DAP using a DAP meter for both intraoral and panoramic examinations. The DAP is therefore recommended for the setting of DRLs.

Magnetic confinement of electron and photon radiotherapy dose: a Monte Carlo simulation with a nonuniform longitudinal magnetic field.

Abstract: It recently has been shown experimentally that the focusing provided by a longitudinal nonuniform high magnetic field can significantly improve electron beam dose profiles. This could permit precise targeting of tumors near critical areas and minimize the radiation dose to surrounding healthy tissue. The experimental results together with Monte Carlo simulations suggest that the magnetic confinement of electron radiotherapy beams may provide an alternative to proton or heavy ion radiation therapy in some cases. In the present work, the external magnetic field capability of the Monte Carlo code PENELOPE was utilized by providing a subroutine that modeled the actual field produced by the solenoid magnet used in the experimental studies. The magnetic field in our simulation covered the region from the vacuum exit window to the phantom including surrounding air. In a longitudinal nonuniform magnetic field, it is observed that the electron dose can be focused in both the transverse and longitudinal directions. The measured dose profiles of the electron beam are generally reproduced in the Monte Carlo simulations to within a few percent in the region of interest provided that the geometry and the energy of the incident electron beam are accurately known. Comparisons for the photon beam dose profiles with and without the magnetic field are also made. The experimental results are qualitatively reproduced in the simulation. Our simulation shows that the excessive dose at the beam entrance is due to the magnetic field trapping and focusing scattered secondary electrons that were produced in the air by the incident photon beam. The simulations also show that the electron dose profile can be manipulated by the appropriate control of the beam energy together with the strength and displacement of the longitudinal magnetic field.

Image quality and dose optimization using novel x-ray source filters tailored to patient size

Abstract: The expanding set of CT clinical applications demands increased attention to obtaining the maximum image quality at the lowest possible dose. Pre-patient beam shaping filters provide an effective means to improve dose utilization. In this paper we develop and apply characterization methods that lead to a set of filters appropriately matched to the patient. We developed computer models to estimate image noise and a patient size adjusted CTDI dose. The noise model is based on polychromatic X-ray calculations. The dose model is empirically derived by fitting CTDI style dose measurements for a demographically representative set of phantom sizes and shapes with various beam shaping filters. The models were validated and used to determine the optimum IQ vs dose for a range of patient sizes. The models clearly show that an optimum beam shaping filter exists as a function of object diameter. Based on noise and dose alone, overall dose efficiency advantages of 50% were obtained by matching the filter shape to the size of the object. A set of patient matching filters are used in the GE LightSpeed VCT and Pro32 to provide a practical solution for optimum image quality at the lowest possible dose over the range of patient sizes and clinical applications. Moreover, these filters mark the beginning of personalized medicine where CT scanner image quality and radiation dose utilization is truly individualized and optimized to the patient being scanned.

Dose measurements near a non-radioactive gold seed using radiographic film.

Abstract: The dose distribution near a non-radioactive gold seed under a 6 MV photon beam was measured using radiographic film, water equivalent bolus and solid water slabs. This type of small seed is typically used as a marker in target positional verification using a portal imager for conformal prostate treatment such as intensity modulated radiation therapy. A stack of three films was placed on top of the seed located on a soft bolus. Solid water slabs were then placed on top of the film. The films were exposed using a small 1x1 cm2 field. Then, using a similar experimental set-up and exposure, another stack of three films was placed under the seed, which was then covered by the soft bolus and solid water slabs. The cross-plane axial beam profiles at different depths, depending on the thickness of the film package, were measured. From the group of beam profiles above and below the seed, the dose distribution along a selected vertical line within the profiles was easily plotted. Compared to the dose with no seed at the isocentre and 5 cm of solid water, there was about a 21% increase in dose at 0.35 mm above the seed. On the other hand, there was about a 22% decrease in dose at the same distance below the seed. The dosimetry of the calibrated film was verified with a MOSFET detector. The change in dose due to the seed by varying the incident beam angles was also measured for this note.

Average glandular dose in routine mammography screening using a Sectra MicroDose Mammography unit.

Abstract: The Sectra MicroDose Mammography system is based on direct photon counting (with a solid-state detector), and a substantially lower dose to the breast than when using conventional systems can be expected. In this work absorbed dose measurements have been performed for the first unit used in routine mammography screening (at the Hospital of Helsingborg, Sweden). Two European protocols on dosimetry in mammography have been followed. Measurement of half value layer (HVL) cannot be performed as prescribed, but this study has demonstrated that non-invasive measurements of HVL can be performed accurately with a sensitive and well collimated solid-state detector with simultaneous correction for the energy dependence. The average glandular dose for a 50 mm standard breast with 50% glandularity, simulated by 45 mm polymethylmethacrylate, was found to be 0.21 and 0.28 mGy in March and December 2004, respectively. These values are much lower than for any other mammography system on the market today. It has to be stressed that the measurements were made using the current clinical settings and that no systematic optimisation of the relationship between absorbed dose and diagnostic image quality has been performed within the present study. In order to further increase the accuracy of absorbed dose measurements for this unit, the existing dose protocols should be revised to account also for the tungsten/aluminium anode/filter combination, the multi-slit pre-collimator device and the occurrence of a dose profile in the scanning direction

Microionization chamber for reference dosimetry in IMRT verification: clinical implications on OAR dosimetric errors

Abstract: Intensity modulated radiotherapy (IMRT) has become a treatment of choice in many oncological institutions. Small fields or beamlets with sizes of 1 to 5 cm2 are now routinely used in IMRT delivery. Therefore small ionization chambers (IC) with sensitive volumes 0.1 cm3 are generally used for dose verification of an IMRT treatment. The measurement conditions during verification may be quite different from reference conditions normally encountered in clinical beam calibration, so dosimetry of these narrow photon beams pertains to the so-called non-reference conditions for beam calibration. This work aims at estimating the error made when measuring the organ at risk's (OAR) absolute dose by a micro ion chamber (microIC) in a typical IMRT treatment. The dose error comes from the assumption that the dosimetric parameters determining the absolute dose are the same as for the reference conditions. We have selected two clinical cases, treated by IMRT, for our dose error evaluations. Detailed geometrical simulation of the microIC and the dose verification set-up was performed. The Monte Carlo (MC) simulation allows us to calculate the dose measured by the chamber as a dose averaged over the air cavity within the ion-chamber active volume (D(air)). The absorbed dose to water (D(water)) is derived as the dose deposited inside the same volume, in the same geometrical position, filled and surrounded by water in the absence of the ion chamber. Therefore, the D(water)/D(air) dose ratio is the MC estimator of the total correction factor needed to convert the absorbed dose in air into the absorbed dose in water. The dose ratio was calculated for the microIC located at the isocentre within the OARs for both clinical cases. The clinical impact of the calculated dose error was found to be negligible for the studied IMRT treatments.

Monte Carlo improvement of dose uniformity in gamma irradiation processing using the GEANT4 code

Abstract: This paper describes a Monte Carlo study on the improvement of dose uniformity within sample carriers, in the Tunisian gamma irradiation facility using the GEANT4 CERN’s code. To validate calculations, dose measurements using Red Perspex dosimeters were performed. The observed good agreement between simulation and experimental data, within a “dummy” product, indicates that the code was used in a correct way. In order to improve dose uniformity within products, three irradiation processing procedures were studied. For comparison purposes, boxes loaded with different density dummy products, were carried out. Based on these results, for a given carrier dimensions, more the product bulk density is higher than a calculated “critical density” more a specific procedure will be performed.